XML 73 R62.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Non-vested Non-qualified Stock Option Activity (Details) - Employee And Consultant [Member] - USD ($)
 1 Months Ended 2 Months Ended
Jun. 11, 2025
Jun. 07, 2025
Jun. 06, 2025
Jul. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options Nonvested, Granted 2,700      
Weighted Average Exercise Price, Granted $ 7.74      
Weighted Average Remaining Contractual Term, Granted 10 years      
2017 Equity Plan and 2021 Equity Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options Nonvested, Granted       2,700
Number of Options Nonvested, Beginning balance    
Weighted Average Grant-Date Fair Value, Nonvested, Beginning balance    
Aggregated Intrinsic Value, Nonvested, Beginning balance    
Grant Date Fair Value Nonvested, Beginning balance    
Weighted Average Grant-Date Fair Value, Nonvested, Granted       $ 7.74
Aggregated Intrinsic Value, Nonvested, Granted       $ 52,056
Grant Date Fair Value Nonvested, Granted       $ 20,898
Number of Options Nonvested, Vested      
Weighted Average Grant-Date Fair Value, Nonvested, Vested      
Grant Date Fair Value Nonvested, Vested      
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited      
Grant Date Fair Value Nonvested, Forfeited      
Number of Options Nonvested, Expired      
Weighted Average Grant-Date Fair Value, Nonvested, Expired      
Grant Date Fair Value Nonvested, Expired      
Number of Options Nonvested, End balance     2,700
Weighted Average Grant-Date Fair Value, Nonvested, End balance     $ 7.74
Aggregated Intrinsic Value, Nonvested, End balance     $ 52,056
Grant Date Fair Value Nonvested, Ending balance     $ 20,898
Number of Options Nonvested, Forfeited      
2017 Equity Plan and 2021 Equity Plan [Member] | Predecessor [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options Nonvested, Granted      
Number of Options Nonvested, Beginning balance  
Weighted Average Grant-Date Fair Value, Nonvested, Beginning balance  
Aggregated Intrinsic Value, Nonvested, Beginning balance  
Grant Date Fair Value Nonvested, Beginning balance  
Weighted Average Grant-Date Fair Value, Nonvested, Granted      
Aggregated Intrinsic Value, Nonvested, Granted      
Grant Date Fair Value Nonvested, Granted      
Number of Options Nonvested, Vested      
Weighted Average Grant-Date Fair Value, Nonvested, Vested      
Grant Date Fair Value Nonvested, Vested      
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited      
Grant Date Fair Value Nonvested, Forfeited      
Number of Options Nonvested, Expired      
Weighted Average Grant-Date Fair Value, Nonvested, Expired      
Grant Date Fair Value Nonvested, Expired      
Number of Options Nonvested, End balance      
Weighted Average Grant-Date Fair Value, Nonvested, End balance      
Aggregated Intrinsic Value, Nonvested, End balance      
Grant Date Fair Value Nonvested, Ending balance      
Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options, Outstanding Beginning   18,296   18,296
Weighted Average Exercise Price, Outstanding Beginning   $ 83.19   $ 83.19
Aggregate Intrinsic Value, Outstanding Beginning    
Weighted Average Exercise Price, Granted       $ 7.74
Aggregate Intrinsic Value, Granted       $ 52,056
Number of Options, Exercised      
Weighted Average Exercise Price, Exercised      
Number of Options, Forfeited      
Weighted Average Exercise Price, Forfeited      
Number of Options, Expired      
Weighted Average Exercise Price, Expired      
Number of Options, Outstanding Ending     18,296 20,996
Weighted Average Exercise Price, Outstanding Ending     $ 83.19 $ 73.49
Aggregate Intrinsic Value, Outstanding Ending    
Number of Options, Exercisable Ending       18,296
Weighted Average Exercise Price, Exercisable Ending       $ 83.19
Aggregate Intrinsic Value, Exercisable Ending      
Weighted Average Remaining Contractual Term, Outstanding   5 years 2 months 12 days   5 years 7 months 6 days
Weighted Average Remaining Contractual Term, Granted       9 years 10 months 24 days
Weighted Average Remaining Contractual Term, Exercisable       5 years
Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member] | Predecessor [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options, Outstanding Beginning  
Weighted Average Exercise Price, Outstanding Beginning  
Aggregate Intrinsic Value, Outstanding Beginning  
Weighted Average Exercise Price, Granted      
Aggregate Intrinsic Value, Granted      
Number of Options, Exercised      
Weighted Average Exercise Price, Exercised      
Number of Options, Forfeited      
Weighted Average Exercise Price, Forfeited      
Number of Options, Expired      
Weighted Average Exercise Price, Expired      
Number of Options, Outstanding Ending      
Weighted Average Exercise Price, Outstanding Ending      
Aggregate Intrinsic Value, Outstanding Ending      
Number of Options, Exercisable Ending      
Weighted Average Exercise Price, Exercisable Ending      
Aggregate Intrinsic Value, Exercisable Ending      
Employee And Consultant [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options Nonvested, Granted       2,700
Employee And Consultant [Member] | 2017 Equity Plan and 2021 Equity Plan [Member] | Predecessor [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Options Nonvested, Granted